Real-time enrollment status for this hematopoietic neoplasm clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 3:23 PM UTC
| NCT Number | NCT06587100 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic Neoplasm |
| Phase | Clinical Trial |
| Target Enrollment | 260 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of California, San Francisco |
| Last Updated on CT.gov | September 23, 2026 (3 weeks ago) |
As of October 19, 2026: Clinical trial NCT06587100 is currently recruiting participants. This clinical trial study for hematopoietic neoplasm is actively seeking new participants at 1 location across the United States. The study is sponsored by University of California, San Francisco. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06587100 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06587100 was last updated 3 weeks ago (September 23, 2026). HelloStudys verifies this status automatically.